YS

YS Biopharma (YS)

YS Biopharma Company Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:YS

1 2 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/24	20 : 30	PR Newswire (US)	YS Biopharma Announces Name Change to LakeShore Biopharma	NASDAQ:YS	YS Biopharma Company Ltd
2024/05/22	05 : 15	PR Newswire (US)	YS Biopharma Announces Results of Extraordinary General Meeting	NASDAQ:YS	YS Biopharma Company Ltd
2024/05/08	05 : 20	PR Newswire (US)	YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer	NASDAQ:YS	YS Biopharma Company Ltd
2024/04/29	21 : 00	PR Newswire (US)	YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule	NASDAQ:YS	YS Biopharma Company Ltd
2024/04/19	20 : 00	PR Newswire (US)	YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024	NASDAQ:YS	YS Biopharma Company Ltd
2024/04/18	21 : 00	PR Newswire (US)	YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine	NASDAQ:YS	YS Biopharma Company Ltd
2024/04/16	21 : 00	PR Newswire (US)	YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024	NASDAQ:YS	YS Biopharma Company Ltd
2024/04/09	21 : 00	PR Newswire (US)	YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine	NASDAQ:YS	YS Biopharma Company Ltd
2024/04/03	21 : 00	PR Newswire (US)	YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility	NASDAQ:YS	YS Biopharma Company Ltd
2024/03/05	22 : 00	PR Newswire (US)	YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries	NASDAQ:YS	YS Biopharma Company Ltd
2024/02/23	07 : 00	PR Newswire (US)	YS Biopharma Announces Results of Extraordinary General Meeting held on February 22, 2024	NASDAQ:YS	YS Biopharma Company Ltd
2024/02/18	18 : 30	PR Newswire (US)	/C O R R E C T I O N -- YS Biopharma Co., Ltd./	NASDAQ:YS	YS Biopharma Company Ltd
2024/02/17	10 : 20	PR Newswire (US)	YS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the Meeting	NASDAQ:YS	YS Biopharma Company Ltd
2024/02/14	22 : 00	PR Newswire (US)	YS Biopharma to Hold an Extraordinary General Meeting on February 22, 2024 pursuant to a Shareholder Requisition to Enhance Corporate Governance	NASDAQ:YS	YS Biopharma Company Ltd
2024/02/14	21 : 50	PR Newswire (US)	YS Biopharma Announces Appointment of New Directors	NASDAQ:YS	YS Biopharma Company Ltd
2024/02/12	22 : 50	PR Newswire (US)	YS Biopharma Responds to a Notice of Extraordinary General Meeting of Shareholders of YS Biopharma Co., Ltd.	NASDAQ:YS	YS Biopharma Company Ltd
2024/02/09	20 : 30	PR Newswire (US)	YS Biopharma Announces US$40 Million Private Placement Financing	NASDAQ:YS	YS Biopharma Company Ltd
2024/02/09	08 : 10	PR Newswire (US)	Shareholders of YS Biopharma Announce an Extraordinary General Meeting	NASDAQ:YS	YS Biopharma Company Ltd
2024/01/23	07 : 00	PR Newswire (US)	YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024	NASDAQ:YS	YS Biopharma Company Ltd
2024/01/08	22 : 00	PR Newswire (US)	YS Biopharma Announces Changes to its Board Committees	NASDAQ:YS	YS Biopharma Company Ltd
2023/12/21	06 : 30	PR Newswire (US)	YS Biopharma Responds to Unauthorized Press Release Regarding Extraordinary General Meeting	NASDAQ:YS	YS Biopharma Company Ltd
2023/12/20	22 : 56	PR Newswire (US)	YS Biopharma Co., Ltd. to Hold Extraordinary General Meeting on December 28, 2023	NASDAQ:YS	YS Biopharma Company Ltd
2023/11/14	22 : 30	PR Newswire (US)	Noble Capital Markets Initiates Coverage on YS Biopharma With Outperform Rating and US$5.25 Price Target	NASDAQ:YS	YS Biopharma Company Ltd
2023/10/31	21 : 30	PR Newswire (US)	YS Biopharma Announces Completion of Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine	NASDAQ:YS	YS Biopharma Company Ltd
2023/10/26	21 : 30	PR Newswire (US)	YS Biopharma Announces Receipt of Nasdaq Notice	NASDAQ:YS	YS Biopharma Company Ltd
2023/09/26	21 : 30	PR Newswire (US)	YS Biopharma Announces First Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine	NASDAQ:YS	YS Biopharma Company Ltd
2023/09/15	21 : 30	PR Newswire (US)	YS Biopharma Granted Patent in the U.S. for Immunotherapy Targeting Chronic Hepatitis B Virus Infection	NASDAQ:YS	YS Biopharma Company Ltd
2023/09/05	21 : 30	PR Newswire (US)	YS Biopharma to Participate in Participate in Citi's 18th Annual Biopharma Conference	NASDAQ:YS	YS Biopharma Company Ltd
2023/08/25	05 : 15	PR Newswire (US)	YS Biopharma Announces Purchase of Shares by Company Officers	NASDAQ:YS	YS Biopharma Company Ltd
2023/08/16	06 : 00	PR Newswire (US)	YS Biopharma Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2024	NASDAQ:YS	YS Biopharma Company Ltd